China Interventional Cardiovascular Device Industry Report,2014-2017

  • September 2014
  • -
  • Research In China
  • -
  • 112 pages

The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing year after year, thereby promoting the development of domestic percutaneous coronary intervention (PCI) market. PCI cases in China totaled 454,505 in 2013, up 16.9% from a year earlier; meanwhile the interventional cardiovascular device industry there was worth RMB20.12 billion.

At present, half of the Chinese interventional cardiovascular device industry is dominated by domestic companies led by MicroPort, Lepu Medical, Lifetech Scientific, and Dalian Yinyi. In 2013, 53.4% of the Chinese market was controlled by domestic companies, 31.2% by foreign counterparts represented by Johnson & Johnson, Medtronic, Boston Scientific, Abbott, B. Braun and Terumo, and 15.4% by those invested by Hong Kong, Macao and Taiwan.

Interventional cardiovascular devices in China include cardiovascular stent, catheter, guidewire, balloon, surgical auxiliary devices, etc., among which cardiovascular stent is predominant.

Cardiovascular stent: In 2013, the Chinese cardiovascular stent market equaled RMB11.2 billion, 78.8% of which was occupied by domestic drug-eluting stents. That same year, 686,000 units of cardiovascular stent were consumed in China, up 11.7% year on year, and drug-eluting stents accounted for 99.5%, indicating that the drug-eluting stent is gradually becoming an important device for interventional cardiovascular therapy.

In addition, Abbott has developed biodegradable stents, which are sold in Europe; Lepu Medical is endeavoring to develop biodegradable stents, which are expected to be available on the market in 2017. Thanks to its excellent performance, biodegradable stents are likely to replace drug-eluting stents gradually in the future, thus becoming the main variety in domestic coronary stent market.

Balloon catheter: In 2013, China’s demand for PTCA balloon catheter amounted to 1.186 million units, 500,000 of which were PTCA balloon catheters for dilatation. With rapid development of local PTCA balloon catheter producers represented by Lepu Medical, MicroPort and JW Medical, domestic PTCA balloon catheters increased its market share from 20% in 2009 to 40% in 2013.

Affected by the implementation of “Regulations on the Centralized Procurement of High-value Medical Consumables”, purchase price of interventional cardiovascular devices will continue to decline, further squeezing profit margins of relevant companies. However, the substantial decline in prices will enable more patients to receive PCI, thus helping the industry maintain a fairly rapid growth rate. It is expected that the Chinese interventional cardiovascular device market will worth RMB41.2 billion by 2017.

China Interventional Cardiovascular Device Industry Report, 2014-2017 focuses on the following:

Status quo of China interventional cardiovascular device industry, including overview, market demand, import & export, competitive landscape and entry barriers;
Development environment of China interventional cardiovascular device industry, embracing macro environment, policy climate and upstream & downstream sectors;
Status quo, competitive landscape, etc. of China interventional cardiovascular device market segments, covering coronary stent, balloon catheter, catheter, guidewire, sheath group and auxiliary devices;
Operation, interventional cardiovascular device business, etc. of 6 foreign and 12 Chinese interventional cardiovascular device companies.

Table Of Contents

1. Overview of Interventional Cardiovascular Device Industry
1.1 Definition
1.2 Classification and Application of Products
1.3 Industry Chain

2. Status Quo of China Interventional Cardiovascular Device Industry
2.1 Overview
2.2 Market Demand
2.3 Import and Export
2.4 Competitive Landscape
2.5 Entry Barriers
2.5.1 Technology
2.5.2 Talent
2.5.3 Patent
2.5.4 Policy
2.5.5 Market Channel

3. Development Environment of China Interventional Cardiovascular Device Industry
3.1 Macro Environment
3.2 Policy Climate
3.2.1 Regulatory Policies
3.2.2 Industrial Policies
3.3 Upstream and Downstream Sectors
3.3.1 Upstream
3.3.2 Downstream

4. Market Segments of China Interventional Cardiovascular Device Industry
4.1 Coronary Stent
4.1.1 Market Profile
4.1.2 Drug-Eluting Stent
4.1.3 Bioabsorbable Stent
4.2 Balloon Catheter
4.2.1 Market Profile
4.2.2 Supply and Demand
4.3 Catheter
4.4 Guidewire
4.5 Sheath Group and Auxiliary Devices

5. Foreign Companies in China
5.1 Johnson and Johnson
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 Interventional Cardiovascular Device Business
5.1.6 Development in China
5.2 Medtronic
5.2.1 Profile
5.2.2 Operation
5.2.3 Interventional Cardiovascular Device Business
5.2.4 Development in China
5.3 Boston Scientific
5.3.1 Profile
5.3.2 Operation
5.3.3 Interventional Cardiovascular Device Business
5.3.4 Development in China
5.4 Abbott Laboratories
5.4.1 Profile
5.4.2 Operation
5.4.3 Interventional Cardiovascular Device Business
5.4.4 Development in China
5.5 B. Braun
5.5.1 Profile
5.5.2 Operation
5.5.3 Interventional Cardiovascular Device Business
5.5.4 Development in China
5.6 Terumo
5.6.1 Profile
5.6.2 Operation
5.6.3 Interventional Cardiovascular Device Business
5.6.4 Development in China

6. Major Domestic Companies
6.1 MicroPort
6.1.1 Profile
6.1.2 Operation
6.1.3 Revenue Structure
6.1.4 Interventional Cardiovascular Device Business
6.1.5 RandD and Investment
6.1.6 Forecast and Outlook
6.2 Lepu Medical
6.2.1 Profile
6.2.2 Operation
6.2.3 Revenue Structure
6.2.4 Gross Margin
6.2.5 Interventional Cardiovascular Device Business
6.2.6 RandD and Investment
6.2.7 Forecast and Outlook
6.3 Lifetech Scientific
6.3.1 Profile
6.3.2 Operation
6.3.3 Revenue Structure
6.3.4 Interventional Cardiovascular Device Business
6.3.5 RandD and Investment
6.3.6 Forecast and Outlook
6.4 JW Medical
6.4.1 Profile
6.4.2 Interventional Cardiovascular Device Business
6.5 Dalian Yinyi
6.5.1 Profile
6.5.2 Interventional Cardiovascular Device Business
6.6 Neich Medical (Shenzhen)
6.6.1 Profile
6.6.2 Interventional Cardiovascular Device Business
6.7 SCW Medicath
6.7.1 Profile
6.7.2 Interventional Cardiovascular Device Business
6.8 Demax Medical
6.8.1 Profile
6.8.2 Interventional Cardiovascular Device Business
6.9 Starway Medical
6.9.1 Profile
6.9.2 Interventional Cardiovascular Device Business
6.10 Synexmed
6.10.1 Profile
6.10.2 Interventional Cardiovascular Device Business
6.11 Sino Medical
6.11.1 Profile
6.11.2 Interventional Cardiovascular Device Business
6.12 AmsinoMed Medical Device
6.12.1 Profile
6.12.2 Interventional Cardiovascular Device Business

7 Forecast and Outlook
7.1 Industry
7.2 Market Segments
7.2.1 Coronary Stent
7.2.2 Balloon Catheter

Companies Mentioned

Johnson and Johnson
Medtronic
Boston Scientific
Abbott Laboratories
B. Braun
Terumo
MicroPort
Lepu Medical
Lifetech Scientific
JW Medical
Dalian Yinyi
Neich Medical (Shenzhen)
SCW Medicath
Demax Medical
Starway Medical
Synexmed
Sino Medical
AmsinoMed Medical Device

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

MediPoint: Aortic Stent Grafts - Global Analysis and Market Forecasts

MediPoint: Aortic Stent Grafts - Global Analysis and Market Forecasts

  • $ 6 495
  • Industry report
  • October 2014
  • by Global Data

MediPoint: Aortic Stent Grafts - Global Analysis and Market Forecasts Summary Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent ...

Cardiac Pacemakers - Global Trends, Estimates and Forecasts, 2012-2018

Cardiac Pacemakers - Global Trends, Estimates and Forecasts, 2012-2018

  • $ 4 450
  • Industry report
  • June 2014
  • by Axis Research Mind

Global Market Watch: Global Cardiac Pacemaker sector is projected to reach US$5.7 billion by 2016. The North American segment accounts for nearly 40% (2015) of the global market share while Europe claims ...

Coronary Stents - Global Trends, Estimates and Forecasts, 2012-2018

Coronary Stents - Global Trends, Estimates and Forecasts, 2012-2018

  • $ 4 450
  • Industry report
  • June 2014
  • by Axis Research Mind

Global Market Watch: Global Coronary Stents sector is projected to reach US$9.5 billion by 2016. The North America accounts for nearly 41% (2015) of the global value while Europe claims approximately 29% ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.